You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

FOLLISTIM AQ CARTRIDGE Drug Profile


✉ Email this page to a colleague

« Back to Dashboard


Summary for Tradename: FOLLISTIM AQ CARTRIDGE
High Confidence Patents:4
Applicants:1
BLAs:1
Pharmacology for FOLLISTIM AQ CARTRIDGE
Established Pharmacologic ClassGonadotropin
Chemical StructureGonadotropins
Note on Biologic Patents

Matching patents to biologic drugs is far more complicated than for small-molecule drugs.

DrugPatentWatch employs three methods to identify biologic patents:

  1. Brand-side disclosures in response to biosimilar applications
  2. These patents were identified from disclosures by the brand-side company, in response to a potential biosimilar seeking to launch. They have a high certainty of blocking biosimilar entry. The expiration dates listed are not estimates — they're expiration dates as indicated by the brand-side company.

  3. General brand-side disclosures
  4. These patents were identified from searching drug labels and other general disclosures from the brand-side company. This list may exclude some of the patents which block biosimilar launch, and some of these patents listed may not actually block biosimilar launch. The expiration dates listed for these patents are estimates, based on the grant date of the patent.

  5. Patents from broad patent text search
  6. For completeness, these patents were identified by searching the patent literature for mentions of the branded or ingredient name of the drug. Some of these patents protect the original drug, whereas others may protect follow-on inventions or even inventions casually mentioning the drug. The expiration dates listed for these patents are estimates, based on the grant date of the patent.

1) High Certainty: US Patents for FOLLISTIM AQ CARTRIDGE Derived from Brand-Side Litigation

No patents found based on brand-side litigation

2) High Certainty: US Patents for FOLLISTIM AQ CARTRIDGE Derived from Company Disclosures

These patents were obtained from company disclosures
Applicant Tradename Biologic Ingredient Dosage Form BLA Patent No. Estimated Patent Expiration Source
Organon Usa Inc., A Subsidiary Of Merck & Co., Inc. FOLLISTIM AQ CARTRIDGE follitropin beta Injection 021211 ⤷  Try a Trial 2015-06-16 Company disclosures
Organon Usa Inc., A Subsidiary Of Merck & Co., Inc. FOLLISTIM AQ CARTRIDGE follitropin beta Injection 021211 ⤷  Try a Trial 2017-01-15 Company disclosures
Organon Usa Inc., A Subsidiary Of Merck & Co., Inc. FOLLISTIM AQ CARTRIDGE follitropin beta Injection 021211 ⤷  Try a Trial 2018-07-23 Company disclosures
Organon Usa Inc., A Subsidiary Of Merck & Co., Inc. FOLLISTIM AQ CARTRIDGE follitropin beta Injection 021211 ⤷  Try a Trial 2018-07-23 Company disclosures
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Patent No. >Estimated Patent Expiration >Source

3) Low Certainty: US Patents for FOLLISTIM AQ CARTRIDGE Derived from Patent Text Search

These patents were obtained by searching patent claims

Supplementary Protection Certificates for FOLLISTIM AQ CARTRIDGE

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
SPC/GB96/011 United Kingdom ⤷  Try a Trial PRODUCT NAME: RECOMBINANT HUMAN FOLLICLE STIMULATING HORMONE; REGISTERED: FI 11529 19940815; FI 11530 19940815; UK EU/1/95/001 19951020; UK EU/1/95/002 19951020; UK EU/1/95/003 19951020; UK EU/1/95/004 19951020; UK EU/1/95/005 19951020; UK EU/1/95/006 19951020; UK EU/1/95/007 19951020; UK EU/1/95/008 19951020; UK EU/1/95/009 19951020; UK EU/1/95/010 19951020; UK EU/1/95/011 19951020; UK EU/1/95/012 19951020; UK EU/1/95/013 19951020; UK EU/1/95/014 19951020; UK EU/1/95/015 19951020; UK EU/1/95/016 19951020
300049 Netherlands ⤷  Try a Trial 300049, 20041031, EXPIRES: 20091030
122010000011 Germany ⤷  Try a Trial PRODUCT NAME: CORIFOLLITROPIN ALFA; REGISTRATION NO/DATE: EU/1/09/609/001-002 20100125
6/2010 Austria ⤷  Try a Trial PRODUCT NAME: CORIFOLLITROPIN ALFA; REGISTRATION NO/DATE: EU/1/09/609/001-002 20100125
300440 Netherlands ⤷  Try a Trial PRODUCT NAME: CORIFOLLITROPIN ALFA; REGISTRATION NO/DATE: EU/1/09/609/001-002 20100125
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.